Regional footprint Private Italian pharmaceutical manufacturer with multiple sites near Milan, head office in Lodi, and a Roma branch, presenting opportunities to expand regional contract manufacturing, distribution partnerships, and localized sales channels in Italy and neighboring markets.

Specialized portfolio Portfolio spans prescription drugs, OTC, medical devices and dietary supplements across 10 therapeutic areas, highlighting cross-sell potential to existing customers and opportunities to introduce new allied products through co-promotion or private-label arrangements.

Innovation focus Strategic emphasis on innovation evidenced by collaborations with In Silico Trials and ongoing product launches such as Class40 and BabyHeART, suggesting opportunities for joint development, digital health initiatives, and advanced R&D collaborations.

Global reach Active international presence with products sold in 90 countries and recent launches in Australia and the UK, presenting sales expansion opportunities through distributor partnerships, regulatory support, and market-entry programs in new regions.

Quality and ethics Foundation on four pillars including Quality and Responsibility, signaling reliability for sensitive sectors like dermo-cosmetics and injectable therapies; ideal for forming quality-focused supply agreements, risk-sharing contracts, and long-term渠道 alliances.